InChI=1S/C27H48O10/c1-9-19-13(3)22(30)14(4)21(29)12(2)11-27(8,34)25(32)15(5)24(16(6)26(33)36-19)37-20-10-18(28)23(31)17(7)35-20/h12-20,22-25,28,30-32,34H,9-11H2,1-8H3/t12-,13+,14+,15+,16-,17+,18+,19-,20+,22+,23+,24+,25-,27-/m1/s1 |
CZYMLHVRCKEDAU-CELNTJITSA-N |
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H]1C |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
(3R,4S,5R,6R,7R,9R,11R,12S,13R,14R)-14-ethyl-4,6,7,12-tetrahydroxy-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-4-yl 2,6-dideoxy-α-Larabino-hexopyranoside
|
(3R,4S,5R,6R,7R,9R,11R,12S,13R,14R)-4-{[(2R,4S,5R,6S)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-6,7,12-trihydroxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
|
IUPAC
|
3-L-olivosyl-erythronolide B
|
ChEBI
|
3-O-(α-L-olivosyl)erythronolide B
|
UniProt
|
L-olivosyl-erythronolide B
|
ChEBI
|
10770761
|
PubMed citation
|
Europe PMC
|
11514520
|
PubMed citation
|
Europe PMC
|
|